Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02582788 · ClinicalTrials.gov registry record · NA
Bathing Additives in Pediatric Atopic Dermatitis
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02582788: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02582788 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02582788, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The current clinical guidelines for management of atopic dermatitis now recommend bleach baths. This requires simply the addition of regular household bleach to twice-weekly baths. At the Mayo Clinic, dilute acetic acid (vinegar) has been recommended for decades in wet wraps to treat patients hospitalized for their atopic dermatitis. However, this practice has not been widely adopted in the pediatric dermatology community. Will the use of dilute acetic acid (vinegar) in twice weekly baths help manage atopic dermatitis in pediatric patients as well as, or better than, the current accepted guidelines?
Interventions
- OTHER Bathing Additive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02582788
The ClinicalTrials.gov registry entry for NCT02582788 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bathing Additive is the first listed.
NCT02582788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02582788 about?
NCT02582788 is a clinical study titled "Bathing Additives in Pediatric Atopic Dermatitis". The current clinical guidelines for management of atopic dermatitis now recommend bleach baths. This requires simply the addition of regular household bleach to twice-weekly baths. At the Mayo Clinic, dilute acetic acid (vinegar) has been recommended for decades in wet wraps to treat patients hospit...
What is the current status of trial NCT02582788?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2015-10. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02582788?
The interventions under investigation include: Bathing Additive (OTHER).
Who is sponsoring clinical trial NCT02582788?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.